含羞草社区

?
?
?
Home Tags Posts tagged with "Zhou Hanshuo"

Tag: Zhou Hanshuo

Firms advise on Insilico Medicine’s HKD2.28bn HKEX IPO

AI drug discovery firm Insilico Medicine listed on the HKEX main board on 30 December 2025

Cross-border medical data compliance in new era of regulation

By Zhou Hanshuo, Jingtian & Gongcheng

Biosafety Law: China’s new, stricter controls

By Zhou Hanshuo and Wang Xiaoyun, Jingtian & Gongcheng

Three questions on medical data compliance

By Zhou Hanshuo and Yuan Lizhi, Jingtian & Gongcheng

Correspondents

Board Observer Regulationvideo

RBI scrutiny tightens over NBFC ‘board observers’

By Swathi Girimaji and Theertha Aiyappa, Bharucha & Partners
Foreign Decree Enforcement Indiavideo

Paper reciprocity undermines foreign decrees

By Ambar Bhushan and Aaryan Goyal, Bharucha & Partners
Biosimilar Patent Litigation India

Trends in biologic patent litigation

By Swati Sharma and Gitika Suri, Cyril Amarchand Mangaldas
konektadong-pinoy-act-expanding-access-redefining-competition

Konektadong Pinoy Act: Expanding access, redefining competition

By Jayson P Baltazar, ACCRALAW

Follow us on LinkedIn